Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction. - Université de Lorraine Access content directly
Journal Articles Journal of the American College of Cardiology Year : 2021

Dates and versions

hal-03362290 , version 1 (01-10-2021)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

João Pedro Ferreira. Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction.. Journal of the American College of Cardiology, 2021, 78 (2), pp.109-111. ⟨10.1016/j.jacc.2021.04.077⟩. ⟨hal-03362290⟩
39 View
115 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More